<DOC>
	<DOCNO>NCT00314145</DOCNO>
	<brief_summary>The purpose study determine non-inferiority seroconversion compare safety tolerability ChimeriVaxTM-JE JE-VAX respective homologous virus strain completion vaccination course .</brief_summary>
	<brief_title>A Safety Efficacy Study Two Japanese Encephalitis Vaccines ChimeriVax™-JE JE-VAX</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects age 18 Subjects good general health . Females must negative pregnancy test use adequate form contraception History vaccination/infection JE Yellow fever flaviviruses History residence/travel flavivirus endemic region History anaphylaxis/serious adverse reaction Administration vaccine within 30 day study treatment period Clinically significant physical exam/medical history/lab abnormality Pregnancy Excessive alcohol/drug abuse Hypersensitivity constituent JEVAX® Blood transfusion/treatment blood product within 6months study study treatment period Known/suspected immunodeficiency Compromised blood brain barrier Employees Clinical Research Organization ( CRO ) /study site staff Any condition would exclude subject .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>